The company is in the early stages of commercializing its Heartflow Plaque Analysis product, a key initiative to diversify revenue beyond its primary product.
Filing excerpt
the commercialization of Heartflow Plaque Analysis is nascent, and we may not be able to achieve or maintain sufficient market acceptance or the levels of utilization we expect from Heartflow Plaque Analysis or any other future product
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-10qproductLaunchGet every 10-Q signal for HeartFlow and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at HeartFlow this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/83907983-8575-4000-bbe5-19a834a99192 returns this record as JSON. POST /v1/companies/enrich returns every signal for heartflow.com.
{
"signal_id": "83907983-8575-4000-bbe5-19a834a99192",
"signal_type": "sec-10q",
"signal_subtype": "productLaunch",
"detected_at": "2026-05-19T10:06:13.235+00:00",
"company": {
"name": "HeartFlow",
"domain": "heartflow.com"
},
"data": {
"detail": "The company is in the early stages of commercializing its Heartflow Plaque Analysis product, a key initiative to diversify revenue beyond its primary product. The 'nascent' stage suggests they may be facing challenges with market acceptance and utilization, creating potential opportunities for vendors specializing in go-to-market strategy, sales enablement, and marketing automation to accelerate adoption.",
"metrics": {
"timeframe": "current_quarter"
},
"summary": "Commercialization of new 'Heartflow Plaque Analysis' product is in a 'nascent' stage",
"excerpts": "the commercialization of Heartflow Plaque Analysis is nascent, and we may not be able to achieve or maintain sufficient market acceptance or the levels of utilization we expect from Heartflow Plaque Analysis or any other future product",
"relevance": 0.7,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1464521/000146452126000071/htfl-20260331x10q.htm",
"filing_date": "2026-05-14",
"filing_year": 2026,
"fiscal_year": 0,
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"technologies_mentioned": [
"AI"
]
}
}
curl https://signals.autobound.ai/v1/signals/83907983-8575-4000-bbe5-19a834a99192 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"heartflow.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.